EP3479829A4 - Mangiferin-6-o-calcium salt and preparation method and use thereof - Google Patents

Mangiferin-6-o-calcium salt and preparation method and use thereof Download PDF

Info

Publication number
EP3479829A4
EP3479829A4 EP17823549.5A EP17823549A EP3479829A4 EP 3479829 A4 EP3479829 A4 EP 3479829A4 EP 17823549 A EP17823549 A EP 17823549A EP 3479829 A4 EP3479829 A4 EP 3479829A4
Authority
EP
European Patent Office
Prior art keywords
mangiferin
preparation
calcium salt
calcium
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17823549.5A
Other languages
German (de)
French (fr)
Other versions
EP3479829A1 (en
Inventor
Houlei Teng
Wei Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Deze Medical Science Co Ltd
Original Assignee
Changzhou Deze Medical Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Deze Medical Science Co Ltd filed Critical Changzhou Deze Medical Science Co Ltd
Publication of EP3479829A1 publication Critical patent/EP3479829A1/en
Publication of EP3479829A4 publication Critical patent/EP3479829A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
EP17823549.5A 2016-07-04 2017-06-28 Mangiferin-6-o-calcium salt and preparation method and use thereof Withdrawn EP3479829A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610510307 2016-07-04
PCT/CN2017/090489 WO2018006737A1 (en) 2016-07-04 2017-06-28 Mangiferin-6-o-calcium salt and preparation method and use thereof

Publications (2)

Publication Number Publication Date
EP3479829A1 EP3479829A1 (en) 2019-05-08
EP3479829A4 true EP3479829A4 (en) 2020-01-08

Family

ID=60912360

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17823549.5A Withdrawn EP3479829A4 (en) 2016-07-04 2017-06-28 Mangiferin-6-o-calcium salt and preparation method and use thereof

Country Status (5)

Country Link
US (1) US10538547B2 (en)
EP (1) EP3479829A4 (en)
JP (1) JP6783329B2 (en)
CN (1) CN109475569B (en)
WO (1) WO2018006737A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009065287A1 (en) * 2007-11-22 2009-05-28 Hainan Deze Drug Research Co., Ltd Novel mangiferin calcium salts, the method for its preparation and its use
EP2444094A1 (en) * 2009-06-16 2012-04-25 Hainan Deze Drug Research Co., Ltd. Mangiferin-berberine salt, manufacturing method and use thereof
WO2016110250A1 (en) * 2015-01-07 2016-07-14 常州德泽医药科技有限公司 Mangiferin-6-o-berberine salt and preparation method and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
CN101108869B (en) * 2006-07-21 2010-06-02 海南德泽药物研究有限公司 Mangiferin salt and method of preparing the same and use thereof
CN1919857A (en) * 2006-08-24 2007-02-28 广西中医学院 Preparation method and application of water-soluble mangiferin monosodium salt
CN101229181A (en) * 2006-09-12 2008-07-30 徐广爱 Medicine compounds for curing diabetes and complications thereof
WO2008061480A1 (en) * 2006-11-24 2008-05-29 Hainan Deze Drug Research Co., Ltd Novel mangiferin calcium salts, the method for its preparation and its use
CN101066275A (en) * 2007-06-12 2007-11-07 广西中医学院 Mangiferin-berberine composition
CN101848922B (en) * 2007-11-22 2013-01-02 海南德泽药物研究有限公司 Novel mangiferin calcium salts, the method for preparation and use thereof
CN101461819A (en) * 2007-12-20 2009-06-24 海南德泽药物研究有限公司 Use of mangiferin calcium salt as peroxisome proliferator-activated receptor agonist
CN101919839A (en) * 2009-06-12 2010-12-22 海南德泽药物研究有限公司 Usage of mangiferin calcium salt taken as AMPK agonist
EP2793827A4 (en) * 2011-12-21 2016-03-02 Colgate Palmolive Co Heatiness and salivary secretory immunoglobulin
CN104557892B (en) * 2013-10-14 2018-01-02 北京大学 A kind of mangiferin unit point derivative and its production and use
CN103816153A (en) * 2013-12-10 2014-05-28 无锡万全医药技术有限公司 Application of compound DZCY06 in preparation of drugs for treating diabetes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009065287A1 (en) * 2007-11-22 2009-05-28 Hainan Deze Drug Research Co., Ltd Novel mangiferin calcium salts, the method for its preparation and its use
EP2444094A1 (en) * 2009-06-16 2012-04-25 Hainan Deze Drug Research Co., Ltd. Mangiferin-berberine salt, manufacturing method and use thereof
WO2016110250A1 (en) * 2015-01-07 2016-07-14 常州德泽医药科技有限公司 Mangiferin-6-o-berberine salt and preparation method and use thereof
EP3243823A1 (en) * 2015-01-07 2017-11-15 Changzhou Deze Medical Science Co., Ltd. Mangiferin-6-o-berberine salt and preparation method and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018006737A1 *

Also Published As

Publication number Publication date
US20190127410A1 (en) 2019-05-02
US10538547B2 (en) 2020-01-21
JP2019519569A (en) 2019-07-11
JP6783329B2 (en) 2020-11-11
WO2018006737A1 (en) 2018-01-11
CN109475569B (en) 2021-10-19
EP3479829A1 (en) 2019-05-08
CN109475569A (en) 2019-03-15

Similar Documents

Publication Publication Date Title
EP3299369A4 (en) Pyrido-azaheterecydic compound and preparation method and use thereof
EP3357521A4 (en) Nanoparticle and preparation method therefor
EP3421503A4 (en) Sugammadex preparation and purification method
EP3244727A4 (en) Insecticidal proteins and methods for their use
EP3159424A4 (en) Rebar and preparation method thereof
EP3351540A4 (en) Cyclohexane derivative or stereoisomer or salt thereof, and preparation and use thereof
EP3377070A4 (en) Compounds and methods of their use
EP3338786A4 (en) Shenlingbaizhu granules and preparation method thereof
EP3141545A4 (en) Polysubstituted pyridylpyrazole amide and preparation method and use thereof
EP3495354A4 (en) Ido1 inhibitor and preparation method and application thereof
EP3124741A4 (en) Self-suspending proppant and preparation and use thereof
EP3451837A4 (en) Insecticidal proteins and methods for their use
EP3412665A4 (en) Suvorexant intermediate and preparation method thereof
EP3395809A4 (en) Benzopiperidine derivative, preparation method thereof and medical use thereof
EP3498707A4 (en) Fgfr4 inhibitor and preparation method and use thereof
EP3398598A4 (en) Sulfonamide derivative and preparation method and use thereof
EP3424899A4 (en) Sacubitril intermediate and preparation method thereof
EP3438105A4 (en) Diaryl- -lactam compound and preparation method and pharmaceutical use thereof
EP3093296A4 (en) Fuc3s4s substituted oligoglycosaminoglycan and preparation method thereof
EP3235851A4 (en) Nylon salt and preparation method therefor
EP3508483A4 (en) Dihydropyrimidine compound and preparation method and use thereof
ZA201704743B (en) Mangiferin-6-o-berberine salt and preparation method and use thereof
EP3459388A4 (en) Toothbrush and preparation method therefor
EP3297498A4 (en) Hanger and method
EP3130340A4 (en) Isoacteoside derivative and preparation method and use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190116

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20191211

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 455/03 20060101ALI20191205BHEP

Ipc: C07D 407/04 20060101AFI20191205BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200921

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIN1 Information on inventor provided before grant (corrected)

Inventor name: TENG, HOULEI

Inventor name: WU, WEI

INTG Intention to grant announced

Effective date: 20210809

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WU, WEI

Inventor name: TENG, HOULEI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20211221